Journal of Medicinal Chemistry · 2016 · 19 citations · 27 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryNeuropharmacologyLigand BindingOpioid AnalgesicsOpioid PharmacologyPeptide Drug DiscoveryReceptor PharmacologyReceptor-ligand InteractionsAgonist ActivityLigand-receptor AffinityOpioid Peptide PharmacologyOpioid Receptor AgonistsOpioid Receptor BindingReceptor Selectivity ProfilingReceptor-ligand SelectivitySystemic Administration
Recently, the tryptophan-containing noncationizable opioid peptides emerged with atypical structure and unexpected in vivo activity. Herein, we describe analogs of the naturally occurring mixed κ/μ-ligand c[Phe-d-Pro-Phe-Trp] 1 (CJ-15,208). Receptor affinity, selectivity, and agonism/antagonism varied upon enlarging macrocycle size, giving the μ-agonist 9 or the δ-antagonist 10 characterized by low nanomolar affinity. In particular, the μ-agonist c[β-Ala-d-Pro-Phe-Trp] 9 was shown to elicit potent antinociception in a mouse model of visceral pain upon systemic administration.
27
A potent and selective endogenous agonist for the µ-opiate receptor
James E. Zadina, Laszlo Hackler, Lin-Jun Ge et al. · Nature · 1997 · 1.3K citations
Peripheral and preemptive opioid antinociception in a mouse visceral pain model
John A. Reichert, Randy S. Daughters, Rachel Rivard et al. · Pain · 2001 · 126 citations